Загрузка...
Nivolumab-Associated Acute Demyelinating Encephalitis: A Case Report and Literature Review
Nivolumab is a checkpoint inhibiting immunotherapeutic agent prescribed for the treatment of resistant cancers. Many immune-related adverse effects including neurological effects have been described, but central nervous system (CNS) toxicities are rarely reported. We present a 59-year-old Caucasian...
Сохранить в:
| Опубликовано в: : | Clin Med Res |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Marshfield Clinic
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6546281/ https://ncbi.nlm.nih.gov/pubmed/31160476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2019.1417 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|